CytoMed Therapeutics
GDTC • NASDAQ • Stock Fundamentals
CytoMed Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Chee Kong Choo, with a market cap of $11.8M.
Market Cap$11.8M
Employees34.0
CEOChee Kong Choo
CountrySingapore
Healthcare
Biotechnology
Most Recent EarningsMay 4, 2026 · todayQ4 2025
View reportFinancials
Based on Q4 2025 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metric
CytoMed Therapeutics FAQ
Common questions about CytoMed Therapeutics
CytoMed Therapeutics (GDTC) has a market capitalization of $11.8M and trades on NASDAQ.
CytoMed Therapeutics has approximately 34 employees.